Liu Wei, Zhang Lei, Xu Zhao
Rheumatic Department, the First Hospital Affiliated to Tianjin College of TCM, Tianjin 300193.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Feb;26(2):157-9.
To study the indication and clinical efficacy of Biqi capsule (BC) in treating patients with rheumatoid arthritis (RA).
One hundred and forty-two RA patients were randomly divided into the BC treated group and the control group treated with nimesulide tablet (NT). There were 36 patients with dampness-heat blockage syndrome type and 35 patients with Qi deficiency and blood stasis syndrome type in each group. The treatment course lasted for 8 weeks.
The total effective rate in the BC group was 66.2% (47 cases), while that in the control group was 60.6% (43 cases). The total effective rate in the patients with Qi deficiency and blood stasis syndrome type in the BC group was 91.4%, superior to that with dampness-heat blockage type (41.7%). Only one patient showed mild adverse reaction in the BC group.
BC is a kind of safe and effective herble medicine for treatment of RA, especially for those of Qi deficiency and blood stasis syndrome type.
研究痹祺胶囊（BC）治疗类风湿关节炎（RA）患者的适应证及临床疗效。
142例RA患者随机分为BC治疗组和尼美舒利片（NT）治疗的对照组。每组中湿热痹阻证型患者36例，气血亏虚证型患者35例。疗程持续8周。
BC组总有效率为66.2%（47例），而对照组为60.6%（43例）。BC组中气血亏虚证型患者的总有效率为91.4%，优于湿热痹阻型（41.7%）。BC组仅1例患者出现轻度不良反应。
BC是治疗RA的一种安全有效的草药，尤其适用于气血亏虚证型患者。
